Name | Title | Contact Details |
---|---|---|
Gerry Pelletier |
Chief Financial Officer | Profile |
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O`Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable.
YmAbs has a powerful set of capabilities for the development of biologics. Our product development team includes some of the most talented and experienced professionals in the antibody industry.
Premera is a Mountlake Terrace, WA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Su International is a Bedminster, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.